tyrphostin a23 has been researched along with Cancer of Pituitary in 1 studies
tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nanzer, AM | 1 |
| Khalaf, S | 1 |
| Mozid, AM | 1 |
| Fowkes, RC | 1 |
| Patel, MV | 1 |
| Burrin, JM | 1 |
| Grossman, AB | 1 |
| Korbonits, M | 1 |
1 other study available for tyrphostin a23 and Cancer of Pituitary
| Article | Year |
|---|---|
Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway.
Topics: Androstadienes; Animals; Butadienes; Carcinogens; Cell Division; Cell Line, Tumor; Dose-Response Rel | 2004 |